Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1 pseudogene 17 is a pseudogene in Homo sapiens, located on chromosome 14 (chr14:19300928-19317893, hg38), with aliases including LINC00516 and BMS1 ribosome biogenesis factor pseudogene 17[3][5]. As a pseudogene, it is not transcribed or translated into functional protein, and does not play a known direct role in cellular pathways or disease processes[2][4]. Pseudogenes such as BMS1P17 usually arise from duplication or mutation of a parental gene (in this case, the functional BMS1, which encodes a GTPase required for ribosomal assembly and is involved in rRNA processing[1]), but lack functions associated with enzymes, receptors, or other drug targets[2][4]. There are currently no known drugs, mechanisms of action, biomarkers, or disease associations linked to BMS1P17, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 pseudogene 17 (BMS1P17).